A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease
Keyword(s):
Keyword(s):
Keyword(s):
1970 ◽
Vol 20
(Issue 12, Part 2)
◽
pp. 6-12
◽
Keyword(s):
2014 ◽
Vol 29
(6)
◽
pp. 514-514
◽
Keyword(s):
2000 ◽
Vol 23
(2)
◽
pp. 82-85
◽
Keyword(s):
2006 ◽
Vol 1
(1)
◽
pp. 13-25
Keyword(s):